Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Wipro, Sun Pharma, Zomato and other hot stocks on March 22

Reliance Industries, Sun Pharma, Dr Reddy’s and other hot stocks to watch out for on December 29

Tata Steel, Sun Pharma, Zee Entertainment, Coal India and other stocks to watch out for on November 12

Sun Pharma, Delta Corp, TCS and other stocks to watch out for on May 28

Airtel, Sun Pharma, Dr. Reddy’s and other stocks to watch out for on May 12

<ul><li>At 7:45 am, the SGX Nifty was up 0.15%, indicating a higher start for Nifty50.</li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider.</a> </li></ul>Indian stock-market indices are likely to start lower on Thursday, led by mixed cues from the global markets. At 7:45 am, the SGX Nifty was up 0.15%, indicating a higher start for Nifty50. The<a href="https://www.businessinsider.in/stock-market/news/us-stocks-climb-higher-in-first-trading-session-of-2021/articleshow/80100896.cms">US stocks declined in the first trading</a> session of 2021 on Monday as investors weighed another spike in virus cases. The Dow Jones Industrial Average closed 382 points lower, and the S&amp;P 500 was down 1.48%. These are the stocks to watch out for during the trading session today: HDFC Mortgage lender HDFC said its disbursements in the individual loan category have grown by 26% during the third quarter ended December 2020. Tech Mahindra Reports indicate that Tech Mahindra may partner Reliance Jio to provide 5G solutions to the world. Tech Mahindra <a href="https://www.business-standard.com/article/companies/tech-mahindra-may-partner-reliance-jio-to-provide-5g-solutions-to-world-121010401357_1.html">said it does not see </a>Jio as competition but rather as an ‘expansion of the industry’ through partnership. Larsen &amp; Toubro (L&amp;T) L&amp;T’s subsidiary has bagged an order worth over ₹7,000 crore from HPCL Rajasthan Refinery, a joint venture between Hindustan Petroleum Corporation (HPCL) and Government of Rajasthan, for setting up a dual feed cracker unit. Bajaj Finance In a stock exchange filing, Bajaj Finance informed its investors that the company added 6 million new loans in the third quarter-ended December 31 as compared to 7.7 million in the same period a year ago. The total deposits of the non-banking financial company (NBFC) rose by 17% to ₹23,800 crore in Q3 (year-on-year). Sun Pharma Sun Pharma has initiated phase two clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis. The study includes 240 subjects and results are expected in 2022. KNR Construction KNR Construction has bagged orders worth ₹603.63 crore from Project Director, Highways (FAC), Chennai Kanyakumari Industrial Corridor Project. The project will be completed within 39 months from the appointed date. Jindal Saw The board of directors of Jindal Saw will be meeting on January 11 to consider the proposal for issuance of non-convertible debentures (NCD) on private placement basis. IIFL Securities A wholly-owned subsidiary of IIFL Securities, IIFL Insurance Brokers has received insurance regulator’s permission for undertaking insurance e-commerce activities in India through Insurance Self Networking Platform. National Fertilizers National Fertilizers has achieved its highest ever production of 9.99 lakh MT urea in the third quarter ended December 31. The plants at Nangal and Panipat achieved their best production during October-December 2020. Edelweiss Financial Services Edelweiss Financial Services raised over ₹240 crore through the issuance of non-convertible debentures (NCDs). SEE ALSO: <a href="https://www.businessinsider.in/business/corporates/news/reliance-says-it-has-absolutely-no-plan-to-enter-contract-farming-urges-government-to-stop-vandalism-amidst-ongoing-farmers-protests/articleshow/80091733.cms" data-type="tilCustomLink">Reliance says it has 'absolutely no plan' to enter contract farming — urges government to stop vandalism amidst ongoing farmers' protests</a> <a href="https://www.businessinsider.in/stock-market/news/big-money-chasing-bitcoin-takes-the-cryptocurrency-to-a-new-record-high-of-34000/articleshow/80090730.cms" data-type="tilCustomLink">Big money chasing Bitcoin takes the cryptocurrency to a new record high of $34,000</a>

Top stocks to watch — HDFC, Tech Mahindra, L&T, Bajaj Finance, IIFL Securities, Sun Pharma, and others

<ul><li>The 30-share BSE index opened 150.72 points higher, and the NSE Nifty was up 0.34% at 13,402.70.</li><li>Here’s a list of the top losers and gainers in the Nifty pack. </li><li>These are the top stocks that are buzzing in trade today.</li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider.</a> </li></ul>Indian equity benchmark indexes touched a fresh lifetime peak in early trade on Tuesday tracking gains in index majors Infosys, HDFC Bank and Maruti amid persistent foreign fund inflow. The 30-share BSE index opened 150.72 points higher, and the NSE Nifty was up 0.34% at 13,402.70. Here’s a list of the top losers and gainers in the Nifty pack. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Top Nifty Gainers </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Top Nifty Losers </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">UltraTech Cement </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Sun Pharma </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">RIL </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Coal India </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">HCL Tech </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">IndusInd Bank </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">UPL </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">JSW Steel </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Maruti Suzuki </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Tech Mahindra </td></tr></tbody></table>*as of December 8, 10:30 am These are the top stocks in news today. Reliance Industries shares trade 3% higher The Mukesh Ambani-owned RIL shares soared 3% after a tepid start on Tuesday. While speaking at the India Mobile Congress 2020, Ambani said<a href="https://www.businessinsider.in/business/telecom/news/mukesh-ambani-says-jio-will-rollout-5g-services-by-june-2021-and-it-will-go-beyond-india/articleshow/79619222.cms"> Jio would start 5G services</a> by the second quarter of CY21. [link it] Canara Bank surges 7% The shares of Canara Bank <a href="https://www.businessinsider.in/finance/banks/news/canara-bank-launches-2000-crore-qip-sets-the-floor-price-at-103-50-per-share/articleshow/79617503.cms">surged almost 7%</a> after the bank announced that it had set a floor price of ₹103.50 per share for its qualified institutional placement (QIP) to raise up to ₹2,000 crore. The bank sought its shareholders’ nod during the annual general meeting, held in August, for raising up to ₹2,000 crore by way of QIP. Coffee Day Enterprise soars 5% The shares of Coffee Day Enterprise soared nearly 5% after it appointed Malavika Hegde, the wife of late VG Siddhartha Hegde, has been appointed as Chief Executive Officer (CEO) of the company from December 7. Jet Airways advances 5% The shares of Jet Airways advanced over 5% after the consortium led by Murari Lal Jalan, and Kalrock Capital said that it plans to <a href="https://www.businessinsider.in/india/news/jet-airways-could-resume-operations-by-summer-of-2021/articleshow/79607964.cms">operationalise Jet Airways by the summer of 2021</a>, subject to certain conditions. Accordingly, the consortium has announced the revival of Jet Airways as a full-service carrier. Godrej Properties gains nearly 3% The shares of Godrej Properties gained nearly 3% after the company on Tuesday announced that it has entered into an outright transaction to purchase a well-located land parcel in Whitefield, Bangalore. Titan gains nearly a percent The shares of Titan gained nearly a percent after its board has decided to scale down the operations of its wholly-owned subsidiary, Favre Leuba AG (FLAG), with immediate effect. Titan said that it has been continuously supporting FLAG, and has made a series of investments. However, the current COVID-19 pandemic has severely impacted the revival plans and prospects. SEE ALSO: <a href="https://www.businessinsider.in/science/health/news/bharat-biotech-applies-for-emergency-use-approval-for-its-covid-19-vaccine-covaxin/articleshow/79617391.cms" data-type="tilCustomLink">Bharat Biotech applies for emergency use approval for its COVID-19 vaccine Covaxin</a> <a href="https://www.businessinsider.in/science/health/news/covid-19-vaccine-in-india-expert-panel-to-review-pfizer-serum-and-bharat-biotechs-emergency-use-application-tomorrow/articleshow/79617336.cms" data-type="tilCustomLink">COVID-19 vaccine in India: Expert panel to review Pfizer, Serum and Bharat Biotech's emergency use application tomorrow</a>

Sensex, Nifty at record high led by surge in IT stocks — these are the top movers in trade

<ul><li>At 7:40 am, the SGX Nifty was down 0.28%, indicating a slow start for Nifty50.</li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider.</a> </li></ul>Indian stock-market indices are likely to start on a tepid note on Wednesday, led by negative cues from the global markets. At 7:40 am, the SGX Nifty was down 0.28%, indicating a slow start for Nifty50. On Monday, the <a href="https://www.businessinsider.in/stock-market/news/us-stocks-slip-as-surging-virus-cases-lead-to-new-lockdowns/articleshow/79610953.cms">US stocks also declined as a surge in COVID-19</a> cases across the country led to renewed lockdown orders. The Dow Jones Industrial Average closed 0.49% lower, and the S&amp;P 500 was down 0.19%. These are the stocks to watch out for during the trading session today: Canara Bank Canara Bank has set a floor price of ₹103.50 per share for its qualified institutional placement (QIP) to raise up to ₹2,000 crore. The bank sought its shareholders’ nod during the annual general meeting, held in August, for raising up to ₹2,000 crore by way of QIP. The shares of Canara Bank ended 6% higher on Monday. Titan Company The Tata Group company, Titan said its board has decided to scale down the operations of its wholly-owned subsidiary, Favre Leuba AG (FLAG), with immediate effect. Titan said that it has been continuously supporting FLAG, and has made a series of investments. However, the current COVID-19 pandemic has severely impacted the revival plans and prospects. The shares of Titan Company ended 0.65% lower on Monday. NBCC State-owned construction firm National Buildings Construction Corporation (NBCC) in a regulatory filing said it had bagged a contract worth ₹325 crore last month. The shares of NBCC ended 3% higher on Monday. HCC HCC defaults on loan payment worth ₹1,836.1 crore. The shares of HCC ended 4% higher on Monday. Sun Pharma The promoter of Sun Pharma, Shanghvi Finance, pledged 10 lakh shares on December 3 in favour of Deutsche Investments India as a security for the loan availed by a subsidiary company. The shares of Sun Pharma ended 2% higher on Monday. Coffee Day Enterprises Malavika Hegde, the wife of late VG Siddhartha Hegde, has been appointed as Chief Executive Officer (CEO) of Coffee Day Enterprises from December 7. The shares of Coffee Day Enterprises are suspended from the Indian stock exchanges. Gujarat State Fertilizers &amp; Chemicals The additional chief secretary to the government, urban development and urban housing department, Mukesh Puri has been appointed as the managing director of Gujarat State Fertilizers &amp; Chemicals. The shares of Gujarat State Fertilizers &amp; Chemicals ended 4% higher on Monday. Goa Carbon Goa Carbon said its production in November was up 59% at 14,309.200 MT as against 9,006.000 MT in October. The shares of Goa Carbon ended 1% lower on Monday. SEE ALSO: <a href="https://www.businessinsider.in/science/health/news/bharat-biotech-applies-for-emergency-use-approval-for-its-covid-19-vaccine-covaxin/articleshow/79617391.cms" data-type="tilCustomLink">Bharat Biotech applies for emergency use approval for its COVID-19 vaccine Covaxin</a> <a href="https://www.businessinsider.in/science/health/news/covid-19-vaccine-in-india-expert-panel-to-review-pfizer-serum-and-bharat-biotechs-emergency-use-application-tomorrow/articleshow/79617336.cms" data-type="tilCustomLink">COVID-19 vaccine in India: Expert panel to review Pfizer, Serum and Bharat Biotech's emergency use application tomorrow</a>

Top stocks to watch — Canara Bank, Sun Pharma, Titan, NBCC, Gujarat State Fertilizers, Coffee Day, and others

<ul><li>The US stocks ended lower on Thursday as hopes of a US coronavirus stimulus deal and US jobless claims weighed heavy on the market. </li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider. </a></li></ul>Amidst mixed sentiments from the global markets, the Indian equities are likely to open flat on Friday. In the Asian market, the SGX Nifty was trading 0.73% higher at 7:51 am, indicating a positive start for Nifty50. However, the US stocks ended lower on Thursday as hopes of a US coronavirus stimulus deal and US jobless claims weighed heavy on the market. The Dow Jones Industrial Average slid 19.80 points, whereas the S&amp;P 500 fell 0.15%. These are the stocks to watch out for during the trading session on October 16: Mindtree Larsen &amp; Toubro (L&amp;T) owned Mindtree posted an 88% jump in its net profit to ₹253.7 crore for the second quarter ended September 30. The company’s revenue for the quarter stood at ₹1,926 crore, marginally up 0.6% year-on-year. The shares of Mindtree ended over 7% lower yesterday. IndiaMart InterMesh The Indian e-commerce company IndiaMart InterMesh has clarified that the media reports claiming potential investment opportunities from Tata Group were incorrect and purely speculative in nature. The shares of IndiaMart InterMesh ended flat yesterday. Persistent Systems The technology services company Persistent Systems said it has entered into an agreement to acquire the US-based CAPIOT Software for $6.34 million (₹465.42 million). The shares of Persistent Systems ended 6% lower yesterday. AstraZeneca Pharma India The drug major AstraZeneca Pharma India said it would launch its Acalabrutinib 100 mg capsules under the brand name ‘Calquence’ on October 21 — the drug is used for the treatment of various types of blood cancers. The shares of AstraZeneca Pharma India ended flat yesterday. Dhanuka Agritech The agrochemical company Dhanuka Agritech’s ₹100 crore buyback will open on October 20 and remain open until November 2. The shares of Dhanuka Agritech ended 2% lower yesterday. Sun Pharma The drug major Sun Pharma clarified to stock exchanges that it had not received any information or notice either from SEBI or anyone regarding the news of SEBI probe of its ex-board member Ashwin Dani. The shares of Sun Pharma ended 3% lower yesterday. Bharti Airtel Competition Commission of India approved completion of the first closing of the telecom giant Bharti Airtel subsidiary Nxtra Data to the Carlyle Group. The shares of Airtel ended 4% lower yesterday. Voltas, Symphony, Bluestar, among others The shares of Voltas, Symphony, Bluestar will also remain in focus during the trade today as the Indian government has banned the import of air conditioners with refrigerants. This move aims to push domestic manufacturing of such goods under a self-reliant India programme. HCL Technologies, Federal Bank, Tata Communications, Bajaj Consumer Care and others <a href="https://www.businessinsider.in/business/corporates/news/hcl-tech-second-quarter-to-see-a-boost-from-cloud-adoption-analysts-expect-it-to-breach-3-5-revenue-growth-guidance/articleshow/78685100.cms">HCL Technologies,</a> Federal Bank, Tata Communications, Bajaj Consumer Care among others are slated to report their second-quarter earnings today. SEE ALSO:<a href="https://www.businessinsider.in/stock-market/news/dow-jones-ends-lower-for-third-day-as-weak-jobless-claims-stimulus-impasse-weigh-on-sentiment/articleshow/78692395.cms" data-type="tilCustomLink" style=""> Dow Jones ends lower for third day as weak jobless claims, stimulus impasse weigh on sentiment</a> <a href="https://www.businessinsider.in/business/corporates/news/hcl-tech-second-quarter-to-see-a-boost-from-cloud-adoption-analysts-expect-it-to-breach-3-5-revenue-growth-guidance/articleshow/78685100.cms" data-type="tilCustomLink" style="">HCL Tech's second quarter to see a boost from cloud adoption — analysts expect it to breach 3.5% revenue growth guidance</a> <a href="https://www.businessinsider.in/defense/news/border-infrastructure-is-not-the-cause-of-friction-between-india-and-china-says-mea-spokesperson/articleshow/78681546.cms" data-type="tilCustomLink">Border infrastructure is not the cause of friction between India and China, says MEA spokesperson</a>

Top stocks to watch — HCL Tech, Airtel, IndiaMart, Mindtree, AstraZeneca Pharma, Sun Pharma, Voltas, and others

<ul><li>At 7:49 am the SGX Nifty was trading 0.69% higher, indicating a positive start for Nifty50.</li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider. </a></li></ul>Amid positive cues from Asian markets, the Indian stock market is likely to open in green. At 7:49 am, the SGX Nifty was trading 0.69% higher. Other Asian markets are also trading in the green — Hong Kong’s Hang Seng Index was up 0.60%, and the Shanghai Composite Index was up nearly 0.18%. These are the stocks to watch out for during the trading session on September 28: Hero MotoCorp According to<a href="https://www.timesnownews.com/business-economy/companies/article/harley-davidson-close-to-deal-with-indias-hero-motocorp-after-stopping-local-manufacturing-sources/657938"> media reports</a>, the US bike maker Harley Davidson is in talks with the Indian two-wheeler major Hero MotoCorp to enter into a distribution arrangement that will allow the Indian company to import and sell Harley bikes as its sole distributor. The shares of Hero MotoCorp ended 3% higher on Friday. SBI and Future Group stocks Media <a href="https://www.thehindubusinessline.com/money-and-banking/biyani-close-to-deal-with-sbi-to-future-proof-insurance-arms/article32709290.ece">reports </a>suggest that as a part of a plan to cut down on debt, the Kishore Biyani-owned Future Group companies are set to ink a deal with State Bank of India for the sale of both the general and life insurance segments. This may move other Future Group stocks as well such as — Future Lifestyle, Future Retail and Future Enterprises. Reliance Industries (RIL) Silver Lake Partners has <a href="https://www.businessinsider.in/retail/news/reliance-retail-raises-1-billion-from-silver-lake-valuing-the-chain-at-57-billion/articleshow/78009435.cms">picked up 1.75% stake</a> in the retail arm of Mukesh Ambani owned RIL. The company invested ₹7,500 crore into its arm Reliance Retail Ventures Ltd (RRVL). The shares of RIL ended 1% higher on Friday. NTPC Ltd The state-owned NTPC Ltd said it has successfully synchronised a 660-MW unit of its supercritical thermal power plant in Bihar with the grid. The company said it would help the commercial generation of electricity from it. The shares of NTPC ended 2.36% higher on Friday. Videocon Industries ad BPCL The state-owned Bharat Petroleum (BPCL) has been forced to pay for its defaulting partner Videocon Industries after it had relied on a rarely used model to acquire a stake in five oil blocks in Brazil, according to <a href="https://energy.economictimes.indiatimes.com/news/oil-and-gas/bpcl-pays-for-defaulting-videocon-in-brazil-oil-block/78355979">reports</a>. The shares of Videocon Industries ended 5% lower on Friday, whereas BPCL shed nearly a percent. Sun Pharma The drug major Sun Pharma in its Annual Report for 2019-20 said the company is looking to expand its speciality business across different regions like Greater China and Japan after having established presence in the US market. The shares of Sun Pharma ended 0.72% higher on Friday. Berger Paints India’s second-largest paint maker, Berger Paints said that despite the coronavirus uncertainty its capital expenditure for this fiscal year remains unaffected and will be the same as last year. The major investment will be in its upcoming Sandila plant near Lucknow of around Rs 260 crore, and the plant is expected to be operational from 2022 onwards. The shares of Berger Paints ended 0.88% higher on Friday. Vodafone Idea The telecom regulator TRAI has decided to drop proceedings against Vodafone Idea in priority plan matter after the telco withdrew contentious claims on faster speed and modified its offering. The shares of Vodafone Idea ended 12% higher on Friday. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/how-to-check-cams-ipo-share-allotment-status/articleshow/78311094.cms" data-type="tilCustomLink">CAMS IPO allotment: Here’s how to check share allotment status</a> <a href="https://www.businessinsider.in/business/auto/news/the-list-of-global-auto-companies-exiting-india-in-last-five-years-including-harley-davidson-fiat-and-general-motors/slidelist/78315633.cms" data-type="tilCustomLink">Harley Davidson is the latest to join the list of global auto companies exiting India in last five years — Here’s a closer look</a> <a href="https://www.businessinsider.in/stock-market/news/heres-how-to-check-chemcon-speciality-chemicals-ipo-share-allotment-status-online/articleshow/78328884.cms" data-type="tilCustomLink">Chemcon IPO allotment: Here’s how to check share allotment status</a>

Top stocks to watch— SBI, RIL, Hero Moto, NTPC, Sun Pharma, Vodafone Idea, Berger Paints and others

<ul><li>At 7:45 am, the SGX Nifty was down 1.14%, indicating a negative start for Nifty50. </li><li>Here’s a list of stocks to watch for in trade today. </li><li><a href="https://www.businessinsider.in/">Check out the latest news and updates on Business Insider. </a></li></ul>The Indian stock market is likely to open in red on Thursday, amid the weak sentiments from the global market. At 7:45 am, the SGX Nifty was down 1.14% pointing towards a negative start for Nifty50. In global markets, the US stocks resumed their heavy sell-off amidst weak macroeconomic indicators and overshadowed recovery outlook on Wednesday. The Dow Jones Industrial Average ended up 525.05 points lower, and the S&amp;P 500 was down 2.37%. These are the stocks to watch out for during the trading session on September 24: Zydus Wellness Zydus Wellness board has approved and authorised the opening of the Qualified Institutional Placement issue at ₹1,775.85 per share on September 23. The shares of Zydus Wellness ended 4% lower yesterday. HDFC Limited Housing Development Finance Corporation Ltd (HDFC) is looking to raise up to ₹5,000 crore by issuing bonds on a private placement basis. The issue size for the secured redeemable Non-Convertible Debentures (NCDs) will be ₹2,500 crore with an option to retain oversubscription of up to ₹2,500 crore, it said in a regulatory filing to stock exchanges. The shares of HDFC Limited ended 0.4% lower yesterday. Infrastructure Leasing &amp; Financial Services (<keyword id="6357293" type="UNKNOWN" weightage="20" keywordseo="ILFS">IL&amp;FS</keyword>) The government of India has extended the term of Uday Kotak as non-executive chairman of debt-ridden IL&amp;FS group by one year. Kotak is also the managing director and chief executive officer of Kotak Mahindra Bank. The shares of IL&amp;FS Transportation Networks ended 4% lower yesterday. Tata Consultancy Services IT major Tata Consultancy Services (TCS) along with the US-based Yale University announced the launch of a new framework that could help ensure privacy and trust in peer-to-peer digital networks. The company said this would be a critical element in enhancing blockchain solutions for greater adoption by consumers. The shares of TCS ended 3% lower yesterday. Future Consumer Future Consumer promoter, Future Capital, invoked 36.6 lakh pledged equity shares. The shares of Future Consumer ended 4% lower yesterday. Sun Pharma Sun Pharma voluntarily recalled one lot of RIOMET ER (metformin hydrochloride for extended-release oral suspension), to the consumer level. The reason for the recall by Sun Pharma came after testing showed high levels of N-nitrosodimethylamine (NDMA), which is above the USFDA norms. The shares of Sun Pharma ended 1.3% lower yesterday. ONGC A fire broke out on Thursday morning at ONGC’s Surat plant. According to <a href="https://www.ndtv.com/india-news/massive-fire-breaks-out-at-ongc-plant-in-gujarats-surat-after-gas-pipeline-blast-2300194">reports</a>, three consecutive blasts took place at two terminals of the Hazira-based ONGC plant in Surat at around 3:30 am. The shares of ONGC ended 2.3% lower yesterday. Angel Broking IPO The ₹600 crore IPO of Angel Broking closes today. The issue was subscribed 1.45 times, a retail portion at 2.8 times on day 2, yesterday. SEE ALSO: <a href="https://www.businessinsider.in/business/startups/news/airbnb-ceo-brian-chesky-on-the-companys-ipo-when-the-markets-ready-for-airbnb-it-will-go-public/articleshow/78276873.cms" data-type="tilCustomLink">Airbnb CEO Brian Chesky on the company's IPO⁠— 'When the market's ready for Airbnb, it will go public'</a> <a href="https://www.businessinsider.in/business/corporates/news/tech-mahindra-subsidiary-sells-stake-in-altiostar-to-rakuten-for-45-million/articleshow/78273567.cms" data-type="tilCustomLink">Tech Mahindra subsidiary sells stake in Altiostar to Rakuten for $45 million</a>

Top stocks to watch— TCS, Future Consumer, ONGC, Zydus Wellness, HDFC, IL&FS, Angel Broking, Sun Pharma and others

<ul><li>This comes after the Drugs Controller General of India gave permission to conduct phase-II clinical trials in April. </li><li><keyword id="44642" type="CITY" weightage="20" keywordseo="Sun-Pharma">Sun Pharma</keyword> will conduct these trials on 210 patients across 12 centers in the country. </li><li>The treatment using AQCH will take about 10 days and the results of these trials will be out by October this year. </li></ul>Sun Pharma has started the second phase of a clinical trial on AQCH, a potential herbal medicine that could treat COVID-19. This comes after the Drugs Controller General of India gave permission to conduct phase-II clinical trials in April. Sun Pharma will conduct these trials on 210 patients across 12 centers in the country. The treatment using AQCH will take about 10 days and the results of these trials will be out by October this year. The stock rallied over 2.5% on Friday. <div type="image" title="Sun Pharma Share price." msid="76210846" hostid="261"></div> “This is the first phytopharmaceutical drug approved for clinical trials by the DCGI as a potential treatment for COVID-19. AQCH has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB, Italy,” <keyword id="207035" type="PERSON" weightage="20" keywordseo="Dilip-Shanghvi">Dilip Shanghvi</keyword>, Managing Director, Sun Pharma said. Sanghvi believes AQCH, a drug being developed to treat dengue, has the potential treatment option for COVID-19 patients. The pancreatitis<a href="http://m/business/Industry/sun-pharma-gets-nod-for-drug-trial-in-covid-19-patients/article31705252.ece"> drug was first identified</a> as a potential medicine for Covid-19 by researchers at University of Tokyo and Leibniz Institute for Primate Research, Germany. Sun Pharma has joined the list of other pharma companies like Glenmark Pharmaceuticals and Strides Pharma Science conducting clinical trials for a drug candidate in India . Ever since China’s scientists released the genome of novel coronavirus, researchers around the world have been racing to develop a vaccine to cure COVID-19. There are at least 70 research efforts underway to develop a coronavirus vaccine around the world. In India, as many as 30 groups are working on a vaccine candidate. SEE ALSO:<a href="https://www.businessinsider.in/business/news/mubadala-to-buy-1-85-pc-stake-in-jio-platforms-for-rs-9093-6-cr/articleshow/76205654.cms"> </a> <a href="https://www.businessinsider.in/business/news/mubadala-to-buy-1-85-pc-stake-in-jio-platforms-for-rs-9093-6-cr/articleshow/76205654.cms">Reliance Industries market value crosses ₹10 lakh crore thanks to Jio's deal with Mubadala</a> <a href="https://www.businessinsider.in/india/news/indias-central-health-ministry-issue-guidelines-for-office-timings/articleshow/76206859.cms">India's central Health Ministry says office timings must be staggered— that and other standard operating procedures for Unlock 1.0</a> <a href="https://www.businessinsider.in/india/news/home-prices-have-to-fall-indian-governments-stern-message-to-realtors-has-other-backers-too/articleshow/76198588.cms">‘Home prices have to fall’⁠— Indian government’s stern message to realtors has other backers too</a>

Sun Pharma’s COVID-19 drug enters phase-II clinical trial⁠— it was first developed to treat dengue

<ul><li>Katherine Eban’s “Bottle of Lies”, launched in US on May 14, warns Americans against generic drugs made abroad.</li><li>The book is an account of the lapses in good manufacturing practices by drug exporters to US.</li><li>Indian companies are big exporters of medicines to US and are already squeezed between shrinking prices and regulatory pressures.</li></ul> Drug makers in India have relied on Americans to buy a big chunk their produce for a long time now. It had paid off well for many years until recently. Between rising competition squeezing prices, regulatory pressure to keep prices lower, and an expanding lawsuit into a purported conspiracy, Indian companies have found the US market to be a tougher place than it ever was. The latest blow has come in the form of a new book, "Bottle of Lies", which "argues that generic drugs are poisoning us," <a href="https://www.nytimes.com/2019/05/13/books/review/bottle-of-lies-katherine-eban.html" data-type="tilCustomLink" target="_blank">according to the New York Times</a>. It's "an invaluable exposé, a reportorial tour de force and a well-turned epic," the reviewer David Dobbs added. The controversy that forms the heart of the book is nearly a decade old. Dinesh Thakur blew the lid on an Indian company Ranbaxy for cutting corners and compromising on quality of drugs before <a href="https://dineshthakur.com/about-2/" data-type="tilCustomLink" target="_blank">quitting the company in 2005</a>. The case unraveled over the years in courtrooms, Congressional hearings, and public discourse that damaged the reputation of India as the 'pharmacy of the world'. The <a href="https://in.reuters.com/article/ranbaxy-settlement-felony-usa-idINDEE94C0DA20130513" data-type="tilCustomLink" target="_blank">case has since been settled</a> at the US Federal Drug Administration (USFDA) for $500 million, <a href="https://www.livemint.com/Companies/tvbrlhX1YGdm7GshBC44VL/Sun-Pharma-completes-Ranbaxy-merger-shares-jump.html" data-type="tilCustomLink" target="_blank">Ranbaxy has been bought over</a> by Sun Pharma, India's largest drug maker with a <a href="https://www.sunpharma.com/sites/all/themes/sunpharma/images/annual/IR%20Presentation%20Feb%202018%20(INR).pdf" data-type="tilCustomLink" target="_blank">huge stake in the US market</a>. But the troubles of Indian drug makers are far from over. On one hand, there is a two-pronged pressure consistently squeezing drug prices-- one from <a href="https://www.businessinsider.in/The-Trump-administration-has-a-little-known-practice-in-the-pharma-industry-in-its-crosshairs/articleshow/64124087.cms" data-type="tilCustomLink" target="_blank">the Trump administration</a> and the other from the <a href="https://www.livemint.com/market/mark-to-market/us-disruption-may-have-singed-indian-pharma-but-it-is-emerging-stronger-1557253325315.html" data-type="tilCustomLink" target="_blank">rising competition</a> in generic drugs. Over the past three years, sales per marketed product (in US) have declined by about 30%, according to a report by global investment bank Nomura in March 2019. At the same time, <a href="https://www.businessinsider.in/seven-indian-pharma-companies-are-being-dragged-into-a-us-lawsuit-over-high-drug-prices/articleshow/69318841.cms" data-type="tilCustomLink" target="_blank">seven Indian companies</a> -- Sun Pharma, Dr Reddy’s Laboratories, Glenmark Pharma, Lupin, Wockhardt, Zydus Pharma and Aurobindo Pharma-- are facing a lawsuit in over 40 American states for acting like a cartel to keep drug prices up. "However, given intensifying competition due to faster generic approvals and regulatory headwinds, the litigation raises the risk associated with the US generics business for companies involved in the litigation," a report from an Indian brokerage, Motilal Oswal, on May 14 said. And Eban's book, which will only further worsen the narrative for the Indian companies, had the endorsement from none other than Dinesh Thakur. “The new book ‘Bottle of Lies’ exposes the truth – and it is critical that Congress hold hearings to address generic drug safety in America,” Thakur said at the book launch in Washington D.C. on Tuesday. Erin Fox, Senior Director of Drug Information and Support Services at University of Utah Health Care (UUHC), who was also present at the launch said that, "The current pass/fail system the U.S. has in place for generic manufacturers overseas is not working. We need either quality metrics for suppliers or more transparency to make quality-based purchasing decisions." Any regulatory action based on this advice will put Indian companies in a deeper pit than the one they are already in. SEE ALSO: <a href="https://www.businessinsider.in/one-chart-from-a-big-pharma-ceo-reveals-how-drug-pricing-in-the-us-really-works/articleshow/68174467.cms" data-type="tilCustomLink" target="_blank">One chart from a big pharma CEO reveals how drug pricing in the US really works</a> <a href="https://www.businessinsider.in/seven-indian-pharma-companies-are-being-dragged-into-a-us-lawsuit-over-high-drug-prices/articleshow/69318841.cms" data-type="tilCustomLink" target="_blank">Seven Indian pharma companies are being dragged into a US lawsuit over high drug prices</a>

A frightening new book on the safety of generic drugs could send India’s pharma industry into an even deeper pit

<ul><li>Over 40 states in the US have filed a lawsuit against 20 drugmakers led by Teva Pharmaceuticals, an Israeli firm, for allegedly conspiring to raise prices of drugs. </li><li>Seven Indian drugmakers - <keyword id="44642" type="CITY" weightage="20" keywordseo="Sun-Pharma">Sun Pharma</keyword>, Dr Reddy’s Laboratories, Glenmark Pharma, Lupin Wockhardt, Zydus Pharma and Aurobindo Pharma - have been named in the antitrust lawsuit. </li><li>The lawsuit alleges that the concerned pharmaceutical firms colluded to raise the prices of over 100 medicines.</li></ul> Over 40 states in the US have <a href="https://www.livemint.com/industry/manufacturing/top-indian-drug-makers-accused-of-fixing-prices-1557774708125.html">filed a lawsuit</a> against 20 drugmakers led by Teva Pharmaceuticals, an Israeli firm, for allegedly conspiring to raise prices of drugs in the US market. Seven Indian drugmakers - Sun Pharma, Dr Reddy’s Laboratories, Glenmark Pharma, Lupin Wockhardt, Zydus Pharma and Aurobindo Pharma - have been named in the antitrust lawsuit, which was filed at the end of last week following the culmination of a multi-year investigation into the US pharma industry. Sun Pharma’s share price on the Bombay Stock Exchange <a href="https://www.google.com/search?q=sun+pharma+share+price&amp;rlz=1C1GCEU_enIN820IN820&amp;oq=sun+pharma+share+price&amp;aqs=chrome..69i57j0l5.4788j1j4&amp;sourceid=chrome&amp;ie=UTF-8">fell 13% </a>yesterday before recovering. The lawsuit alleges that the concerned pharmaceutical firms colluded to raise the prices of over 100 medicines and divide up the addressable market for the medicines as opposed to competing normally against each other. Teva is said to be <a href="https://www.philly.com/business/generics-teva-pennsylvania-new-jersey-drugs-price-fixing-20190513.html">the driving force </a>behind the collusion. Between 2013 and 2015, the Israel drugmaker reportedly fixed prices on 86 medicines, the complaint from the states alleged. The price increases on some drugs were as high as 1,000%. The drugmakers have to deal with more than just the lawsuit from the states. Even the US Department of Justice is investigating the companies for antitrust violations. Speaking on the matter, a spokesperson for Sun Pharma told <a href="https://www.livemint.com/industry/manufacturing/top-indian-drug-makers-accused-of-fixing-prices-1557774708125.html">Mint</a>, ““We believe the allegations made in these lawsuits are without merit and we will continue to vigorously defend against them." If successfully argued, the lawsuit could result in billions of dollars worth of fines for the concerned companies. The fines for Indian pharma firms are expected to be in <a href="https://timesofindia.indiatimes.com/business/india-business/7-indian-pharma-cos-face-lawsuits-from-over-40-us-states/articleshow/69315711.cms">the tens of millions of range</a>, since their participation was reportedly limited. For their part, the drugmakers have argued that the price increases were a result of market factors like supply shocks and consolidation among rivals. SEE ALSO: <a href="https://www.businessinsider.in/generic-drugs-are-americas-solution-to-high-branded-drug-prices-but-recent-events-suggest-the-markets-not-working/articleshow/67200320.cms">Generic drugs are America's solution to high branded drug prices. But recent events suggest the market's not working</a>

You Searched For "Sun Pharma share price" and got 14 results

Wipro, Sun Pharma, Zomato and other hot stocks on March 22

Rounak Jain

Reliance Industries, Sun Pharma, Dr Reddy’s and other hot stocks to watch out for on December 29

Rounak Jain

Tata Steel, Sun Pharma, Zee Entertainment, Coal India and other stocks to watch out for on November 12

Rounak Jain

Sun Pharma, Delta Corp, TCS and other stocks to watch out for on May 28

Rounak Jain

Airtel, Sun Pharma, Dr. Reddy’s and other stocks to watch out for on May 12

Rounak Jain

Top stocks to watch — HDFC, Tech Mahindra, L&T, Bajaj Finance, IIFL Securities, Sun Pharma, and others

Navdeep Yadav

Sensex, Nifty at record high led by surge in IT stocks — these are the top movers in trade

Navdeep Yadav

Top stocks to watch — Canara Bank, Sun Pharma, Titan, NBCC, Gujarat State Fertilizers, Coffee Day, and others

Navdeep Yadav

Top stocks to watch — HCL Tech, Airtel, IndiaMart, Mindtree, AstraZeneca Pharma, Sun Pharma, Voltas, and others

Navdeep Yadav

Top stocks to watch— SBI, RIL, Hero Moto, NTPC, Sun Pharma, Vodafone Idea, Berger Paints and others

Navdeep Yadav

Top stocks to watch— TCS, Future Consumer, ONGC, Zydus Wellness, HDFC, IL&FS, Angel Broking, Sun Pharma and others

Navdeep Yadav

Sun Pharma’s COVID-19 drug enters phase-II clinical trial⁠— it was first developed to treat dengue

Preeti Soni

A frightening new book on the safety of generic drugs could send India’s pharma industry into an even deeper pit

Sriram Iyer

Seven Indian pharma companies are being dragged into a US lawsuit over high drug prices

BI India Bureau

Popular Keywords

Buying Guides